ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 1.7.2 (20 November 2019) - 2999001/03280432CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120210414W173deBibliographieenBibliographyfrBibliographieEP16777107.0201604042017110620190617enenen201562143772 P20150406US2021041420211520180214201807202103102021102020093020210414202115A61P 35/00 20060101AFI20200826BHEP A61K 38/00 20060101ALI20200826BHEP C07K 14/00 20060101ALI20200826BHEP C07K 14/705 20060101ALI20200826BHEP C07K 16/10 20060101ALI20200826BHEP C07K 16/28 20060101ALI20200826BHEP C07K 14/435 20060101ALI20200826BHEP G01N 33/574 20060101ALI20200826BHEP A61K 38/17 20060101ALI20200826BHEP deDE-NOVO-BINDUNGSDOMÄNE MIT POLYPEPTIDEN UND VERWENDUNGEN DAVONenDE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOFfrPOLYPEPTIDES CONTENANT UN DOMAINE DE LIAISON DE NOVO ET LEURS UTILISATIONSWO-A1-2010/124829WO-A1-2014/138805US-A1- 2014 271 582PER-ÅKE NYGREN: "Alternative binding proteins: Affibody binding proteins developed from a small three-helix bundle scaffold : Affibody binding proteins", FEBS JOURNAL, vol. 275, no. 11, 24 April 2008 (2008-04-24), pages 2668-2676, XP055504842, GB ISSN: 1742-464X, DOI: 10.1111/j.1742-4658.2008.06438.xNOAD R ET AL: "Virus-like particles as immunogens", TRENDS IN MICROBIOLOGY, ELSEVIER SCIENCE LTD., KIDLINGTON, GB, vol. 11, no. 9, 1 September 2003 (2003-09-01), pages 438-444, XP003004438, ISSN: 0966-842X, DOI: 10.1016/S0966-842X(03)00208-7ANDREAS PL?CKTHUN: "Designed Ankyrin Repeat Proteins (DARPins): Binding Proteins for Research, Diagnostics, and Therapy", ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, vol. 55, no. 1, 6 January 2015 (2015-01-06), pages 489-511, XP055217451, ISSN: 0362-1642, DOI: 10.1146/annurev-pharmtox-010611-134654DAVID LAFLEUR ET AL: "Monoclonal antibody therapeutics with up to five specificities: Functional enhancement through fusion of target-specific peptides", MABS, vol. 5, no. 2, 1 March 2013 (2013-03-01), pages 208-218, XP055196030, ISSN: 1942-0862, DOI: 10.4161/mabs.23043PLUCKTHUN.: 'Designed ankyrin repeat proteins (DARPins): binding proteins for research, diagnostics, and therapy.' ANNU REV PHARMACOL TOXICOL. vol. 55, January 2015, pages 489 - 511, XP055217451WALKER ET AL.: 'Targeting high-risk pediatric solid tumors with CAR T cells directed against ALK (anaplastic lymphoma kinase, CD 246).' J IMMUNOTHER CANCER vol. 2, no. SUPPL, 2014, page P40, XP021202601MARDIROS ET AL.: 'T cells expressing CD 123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia.' BLOOD vol. 122, no. 18, 2013, pages 3138 - 3148, XP002727946DATABASE UNIPROT [Online] 07 January 2015 'Cytoplasmic dynein 2 heavy chain 1.', XP055488729 Retrieved from UNIPROTKB Database accession no. 9ZSS72018101021155053.820210203LAFLEUR, David, William3142 Quesada Street NWWashington, DC 20015USHILBERT, David, M.25 W Watkins Mill RdGaithersburg, MD 20878USSubdomain, LLC101626505P113352EP CLM3142 Quesada Street NWWashington, DC 20015USArcellx, Inc.101886050P113352EP CLM25 W Watkins Mill RdGaithersburg, MD 20878USD Young & Co LLP101533551120 HolbornLondon EC1N 2DYGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRUS201602586820160404enWO201616430520161013201641